Patricio Grob, DO
Orthopaedic Trauma · Whippany, NJNPI 1316912884
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 20 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 7 manufacturers reported payments, led by Stryker at 56.8% of the total. Reporting peaked in 2021 at $458 and has fallen 81.1% since, to $87 in 2025.
Across 20 payments — averaging $66.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$761
- Johnson & Johnson$269
- Innovation Technologies Inc$130
- Medical Device Business Services, Inc.$111
- Kerecis Limited$29
- Si-bone, Inc.$24
- plus $14 from 1 others
What the payments were for
- Food & beverage$1,338100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 7 | $761 |
| Johnson & Johnson | 5 | $269 |
| Innovation Technologies Inc | 1 | $130 |
| Medical Device Business Services, Inc. | 2 | $111 |
| Kerecis Limited | 1 | $29 |
| Si-bone, Inc. | 3 | $24 |
| Pfizer | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MOJAVE EXPANDABLE INTERBODY SYSTEM$321
- AIRO$162
- AVS ANCHOR-L$147
- Irrisept$130
- CONDUIT$110
How this compares
Too few orthopaedic trauma providers in New Jerseyto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tramadol Hcl | 20 | $320 |
| Gabapentin | 16 | $110 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic trauma in Whippany
- Richard SchenkWhippany$10K
- Frank LiporaceJersey City$3.6M
- Mark ReillyNewark$540K
- Milan SenClifton$152K
- Mark AdamsNewark$38K
- Julie KellerMaywood$29K
- Joseph GallowayNewark$15K
- Sergio PulidoMoorestown$10K
- David HamptonMedford$9K
- Steven MennonaManasquan$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.